Controlled-release potassium supplementation.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002712:Chlorides / Q000097:blood; D002740:Chlorothiazide / Q000009:adverse effects; D002752:Chlorthalidone / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D005665:Furosemide / Q000009:adverse effects; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011189:Potassium Chloride / Q000008:administration & dosage / Q000627:therapeutic use*; D011191:Potassium Deficiency / Q000139:chemically induced / Q000188:drug therapy*
D002712:Chlorides; D003692:Delayed-Action Preparations; D006852:Hydrochlorothiazide; D011189:Potassium Chloride; D002740:Chlorothiazide; D005665:Furosemide; D002752:Chlorthalidone